We are live on
!
Find out more
T
TOBAM Portfolio holdings
AUM
$384M
1-Year Est. Return
10.32%
This Fund
S&P 500
This Quarter
Est. Return
+0.57%
1 Year Est. Return
+10.32%
3 Year Est. Return
+36.67%
5 Year Est. Return
+41.37%
10 Year Est. Return
+233.72%
AUM
$234M
AUM Growth
-$93.7M
(-29%)
Cap. Flow
-$86.8M
Cap. Flow
% of AUM
-37.11%
Top 10 Holdings %
Top 10 Hldgs %
27.68%
Holding
338
New
19
Increased
53
Reduced
178
Closed
87
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Electronic Arts
EA
|
+$3.29M |
| 2 |
West Pharmaceutical
WST
|
+$2.66M |
| 3 |
Broadcom
AVGO
|
+$2.25M |
| 4 |
AXON
Axon Enterprise
AXON
|
+$2.12M |
| 5 |
Nike
NKE
|
+$2.06M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$4.16M |
| 2 |
United Therapeutics
UTHR
|
+$4.06M |
| 3 |
RB Global
RBA
|
+$3.88M |
| 4 |
Toro Company
TTC
|
+$3.77M |
| 5 |
J.M. Smucker
SJM
|
+$3.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.08% |
| 2 | Consumer Staples | 21.87% |
| 3 | Technology | 13.57% |
| 4 | Financials | 11.99% |
| 5 | Communication Services | 10.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Vertex Pharmaceuticals
VRTX
$123B
| $1K | ﹤0.01% |
3
-361
| -99% | -$168K |
|
252
Agilent Technologies
A
$37.1B
| – | – |
-452
| Closed | -$61K |
|
253
Abbott
ABT
$175B
| – | – |
-2,358
| Closed | -$267K |
|
254
Analog Devices
ADI
$183B
| – | – |
-585
| Closed | -$124K |
|
255
Aflac
AFL
$63.5B
| – | – |
-559
| Closed | -$58K |
|
256
Arthur J. Gallagher & Co
AJG
$65.2B
| – | – |
-325
| Closed | -$92K |
|
257
Ascendis Pharma A/S
ASND
$17.1B
| – | – |
-1,622
| Closed | -$223K |
|
258
AutoZone
AZO
$49.7B
| – | – |
-32
| Closed | -$102K |
|
259
Becton Dickinson
BDX
$43.6B
| – | – |
-312
| Closed | -$71K |
|
260
Bausch Health
BHC
$1.8B
| – | – |
-15,034
| Closed | -$175K |
|
261
Biogen
BIIB
$30.4B
| – | – |
-3,358
| Closed | -$514K |
|
262
Booking.com
BKNG
$141B
| – | – |
-1,150
| Closed | -$229K |
|
263
Citigroup
C
$217B
| – | – |
-1,975
| Closed | -$139K |
|
264
Conagra Brands
CAG
$6.83B
| – | – |
-26,458
| Closed | -$734K |
|
265
Cameco
CCJ
$37.3B
| – | – |
-13,674
| Closed | -$1.01M |
|
266
Comcast
CMCSA
$85B
| – | – |
-5,326
| Closed | -$200K |
|
267
Salesforce
CRM
$140B
| – | – |
-1,249
| Closed | -$418K |
|
268
Cognizant
CTSH
$21.2B
| – | – |
-1,114
| Closed | -$86K |
|
269
CVS Health
CVS
$137B
| – | – |
-4,348
| Closed | -$195K |
|
270
Deere & Co
DE
$161B
| – | – |
-297
| Closed | -$126K |
|
271
D.R. Horton
DHI
$42.4B
| – | – |
-383
| Closed | -$54K |
|
272
Danaher
DHR
$144B
| – | – |
-915
| Closed | -$210K |
|
273
Digital Realty Trust
DLR
$64.3B
| – | – |
-445
| Closed | -$79K |
|
274
eBay
EBAY
$49.8B
| – | – |
-1,635
| Closed | -$101K |
|
275
Ecolab
ECL
$76.8B
| – | – |
-415
| Closed | -$97K |
|
Similar funds
PCM
DFA
BAMG
DR
GCP
DC
GA
VI
TOBAM's Q1 2025 Portfolio in Review
As of Q1 2025, TOBAM held 338 positions worth $234M, down 29% from $328M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
TOBAM withdrew a net $86.8M in Q1 2025, closing 87 positions and reducing 178 holdings. Its most notable exit was Toro Company, an estimated $3.77M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 29% a quarter earlier, followed by Consumer Staples and Technology.
Against the trend, TOBAM opened a new position in Expeditors International worth $1.14M.
- TOBAM's largest Q1 2025 buy was Expeditors International: 9,454 shares worth $1.14M.
- TOBAM added most to Electronic Arts in Q1 2025, an estimated $3.29M increase.
- TOBAM's biggest Q1 2025 reduction was Pfizer, cutting an estimated $4.16M.
- TOBAM fully exited Toro Company in Q1 2025, selling an estimated $3.77M.
- TOBAM's ten largest holdings make up 28% of its $234M portfolio in Q1 2025.
- TOBAM opened 19 new positions and closed 87 in Q1 2025.
- TOBAM's portfolio value fell 29% quarter-over-quarter to $234M.
Based on TOBAM's 13F filing for Q1 2025, filed 16 Apr 2025.